SE434744B - Forfarande for framstellning av aminoalkoholderivat - Google Patents

Forfarande for framstellning av aminoalkoholderivat

Info

Publication number
SE434744B
SE434744B SE7612554A SE7612554A SE434744B SE 434744 B SE434744 B SE 434744B SE 7612554 A SE7612554 A SE 7612554A SE 7612554 A SE7612554 A SE 7612554A SE 434744 B SE434744 B SE 434744B
Authority
SE
Sweden
Prior art keywords
aminoal
preparing
procedure
alcohol derivatives
derivatives
Prior art date
Application number
SE7612554A
Other languages
English (en)
Swedish (sv)
Other versions
SE7612554L (sv
Inventor
G Lambelin
C Gillet
J Roba
R Roncucci
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of SE7612554L publication Critical patent/SE7612554L/xx
Publication of SE434744B publication Critical patent/SE434744B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SE7612554A 1975-11-18 1976-11-11 Forfarande for framstellning av aminoalkoholderivat SE434744B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7535217A FR2332010A1 (fr) 1975-11-18 1975-11-18 Amino-alcool heterocyclique, son sel et son procede de preparation

Publications (2)

Publication Number Publication Date
SE7612554L SE7612554L (sv) 1977-05-19
SE434744B true SE434744B (sv) 1984-08-13

Family

ID=9162563

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612554A SE434744B (sv) 1975-11-18 1976-11-11 Forfarande for framstellning av aminoalkoholderivat

Country Status (21)

Country Link
JP (2) JPS5297952A (ja)
AT (1) AT355566B (ja)
AU (1) AU510315B2 (ja)
BE (1) BE848496A (ja)
CA (1) CA1094088A (ja)
CH (2) CH623321A5 (ja)
DE (1) DE2651572C2 (ja)
DK (1) DK151330C (ja)
ES (1) ES453389A1 (ja)
FI (1) FI763265A (ja)
FR (1) FR2332010A1 (ja)
GB (1) GB1565080A (ja)
GR (1) GR62012B (ja)
IE (1) IE44265B1 (ja)
IL (1) IL50932A (ja)
MX (1) MX4881E (ja)
NL (1) NL180936C (ja)
NZ (1) NZ182665A (ja)
PT (1) PT65853B (ja)
SE (1) SE434744B (ja)
ZA (1) ZA766907B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation
US4562200A (en) * 1983-06-30 1985-12-31 American Home Products Corporation 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives
US4521606A (en) * 1983-06-30 1985-06-04 American Home Products Corp. 5-Indolyl substituted aminoethanols
US4622399A (en) * 1983-06-30 1986-11-11 American Home Products Corporation Bicyclo-heterocyclic nitrogen substituted aminoethanol derivatives
ATE194982T1 (de) 1992-04-24 2000-08-15 Takeda Chemical Industries Ltd Benzoxazepin-derivate als cholinesterase- inhibitoren
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5656661A (en) * 1994-07-27 1997-08-12 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5684002A (en) * 1994-09-07 1997-11-04 The Procter & Gamble Company Dihydorbenzofuran and related compounds useful as anti-inflammatory agents
EP0882707B1 (en) 1996-01-10 2003-10-08 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
US5672620A (en) * 1996-02-01 1997-09-30 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5684031A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
AU6218598A (en) * 1997-01-30 1998-08-25 Synthelabo Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application
DE997458T1 (de) * 1997-07-03 2001-03-01 Asahi Chemical Ind Tricyclische verbindungen mit gesättigten ringen und diese enthaltende medizinische zubereitungen
DK1277736T3 (da) 2000-04-28 2007-10-01 Asahi Kasei Pharma Corp Hidtil ukendte bicykliske forbindelser
EP1935882B1 (en) 2001-10-25 2011-02-09 Asahi Kasei Pharma Corporation Bicyclic compounds
JPWO2010041568A1 (ja) 2008-10-09 2012-03-08 旭化成ファーマ株式会社 インダゾール誘導体
KR20110050734A (ko) 2008-10-09 2011-05-16 아사히 가세이 파마 가부시키가이샤 인다졸 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
US3255249A (en) * 1963-04-26 1966-06-07 Ici Ltd 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols
CH442302A (de) * 1964-04-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Indolderivates
FR2138488A1 (en) * 1971-05-27 1973-01-05 Lipha 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity

Also Published As

Publication number Publication date
BE848496A (fr) 1977-05-18
DK151330C (da) 1988-04-25
AU1977976A (en) 1978-05-25
AU510315B2 (en) 1980-06-19
JPS63435B2 (ja) 1988-01-07
NZ182665A (en) 1978-11-13
JPS57145843A (en) 1982-09-09
JPS6017778B2 (ja) 1985-05-07
SE7612554L (sv) 1977-05-19
IE44265B1 (en) 1981-09-23
FI763265A (ja) 1977-05-19
NL7612794A (nl) 1977-05-23
GR62012B (en) 1979-02-15
FR2332010B1 (ja) 1979-06-29
NL180936B (nl) 1986-12-16
ZA766907B (en) 1977-10-26
JPS5297952A (en) 1977-08-17
PT65853A (fr) 1976-12-01
MX4881E (es) 1982-11-30
ES453389A1 (es) 1977-11-16
IL50932A (en) 1984-01-31
ATA854376A (de) 1979-08-15
DK151330B (da) 1987-11-23
DE2651572A1 (de) 1977-06-08
IE44265L (en) 1977-05-18
CH623321A5 (en) 1981-05-29
DK517076A (da) 1977-05-19
AT355566B (de) 1980-03-10
FR2332010A1 (fr) 1977-06-17
IL50932A0 (en) 1977-01-31
GB1565080A (en) 1980-04-16
NL180936C (nl) 1987-05-18
DE2651572C2 (de) 1982-05-19
PT65853B (fr) 1978-05-15
CH622770A5 (en) 1981-04-30
CA1094088A (en) 1981-01-20

Similar Documents

Publication Publication Date Title
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
SE434744B (sv) Forfarande for framstellning av aminoalkoholderivat
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
NO152220C (no) Fremgangsmaate for fremstilling av sesquiterpenderivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE7802609L (sv) Forfarande for framstellning av 1-azaxanton-3-karboxylsyraderivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
NO791604L (no) Fremangsmaate for fremstilling av di-o-n-alkyl-glycerolderivater
SE428800B (sv) Forfarande for framstellning av 2-subtituerade 5-alkylresorcinoler
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423902B (sv) Forfarande for framstellning av purinderivat
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE7707407L (sv) Forfarande for framstellning av cefamderivat
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE433210B (sv) Forfarande for framstellning av ny cyklohexylfenylderivat
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE413243B (sv) Forfarande for framstellning av vissa angivna farmaceutiskt anvendbara aminoalkanol-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7612554-1

Effective date: 19910611

Format of ref document f/p: F